FindTrial
Sign In

digital mammography

PROCEDURE14 trials

Sponsors

University of Michigan, Boston Medical Center, University of Alabama at Birmingham, Northwestern University, Universitaire Ziekenhuizen KU Leuven

Conditions

Breast CancerBreast NeoplasmsBreast ScreeningDCISData CollectionDuctal Carcinoma in SituHealthy, no Evidence of DiseaseInvasive Cancer

Phase 2

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Active, not recruitingNCT01196936
University of Alabama at BirminghamBreast Cancer
Start: 2010-09-30End: 2028-12-11Updated: 2026-01-05

Phase 3

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Active, not recruitingNCT03233191
ECOG-ACRIN Cancer Research GroupBreast Screening
Start: 2017-09-28End: 2030-12-31Target: 108508Updated: 2026-03-23

Phase 4

Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM)
TerminatedNCT04625517
University of Texas Southwestern Medical CenterBreast Cancer
Start: 2020-01-22End: 2022-06-15Updated: 2023-10-12

Unknown Phase

Digital Mammography: Computer-Aided Breast Cancer Diagnosis
CompletedNCT00732433
University of MichiganTumors, Breast
Start: 2000-06-30End: 2020-01-31Updated: 2020-01-29
Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer
CompletedNCT00896649
Boston Medical CenterBreast Cancer
Start: 2009-02-28End: 2017-01-31Updated: 2017-05-09
Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer
TerminatedNCT01259076
Northwestern UniversityHealthy, no Evidence of Disease
Start: 2011-02-28End: 2014-07-31Updated: 2015-04-10
Data Collection for CAD Evaluation
RecruitingNCT01600144
Universitaire Ziekenhuizen KU LeuvenData Collection
Start: 2012-03-31End: 2025-08-31Target: 100Updated: 2024-07-03
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
NCT01666171
Cancer and Leukemia Group BBreast Cancer
Start: 2012-08-31Target: 458Updated: 2013-07-10
Management of Low-risk (Grade I and II) DCIS
Active, not recruitingNCT02492607
The Netherlands Cancer InstituteDCIS
Start: 2017-02-13End: 2034-02-01Target: 2500Updated: 2026-01-26
The Digital Breast Tomosynthesis Trial in Bergen
CompletedNCT02835625
Norwegian Institute of Public HealthBreast Neoplasms
Start: 2016-01-31End: 2021-05-31Updated: 2024-08-28
The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness
NCT02909426
Soonchunhyang University HospitalDuctal Carcinoma in Situ, Invasive Cancer
Start: 2016-05-02End: 2023-12-31Updated: 2021-10-07
Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography
CompletedNCT02995980
University of Alabama at BirminghamBreast Cancer
Start: 2015-11-30End: 2018-05-31Updated: 2019-09-25
Tomosynthesis as Primary Test for Breast Cancer Screening
Active, not recruitingNCT04461808
Azienda USL Reggio Emilia - IRCCSBreast Cancer
Start: 2019-07-15End: 2029-04-30Updated: 2025-06-25
Cone Beam Breast CT for Breast Cancer Screening
Active, not recruitingNCT05036096
Koning CorporationBreast Cancer
Start: 2021-10-30End: 2026-12-30Target: 1024Updated: 2026-02-05

Related Papers

Abstract PS3-01-30: Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32
Clinical Cancer Research2026-02-17
Quality control for digital tomosynthesis in the ECOG‐ACRIN EA1151 TMIST trial
Medical Physics2023-10-132 citations
Adjusting the TMIST study design to accommodate slower than expected accrual: ECOG-ACRIN EA1151.
Journal of Clinical Oncology2022-06-011 citations
Engaging the radiology community in the National Clinical Trials Network: The ECOG-ACRIN TMIST experience.
Journal of Clinical Oncology2021-05-20
ECOG-ACRIN tomosynthesis mammographic imaging screening trial (EA1151).
Journal of Clinical Oncology2020-05-201 citations
The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).
Journal of Clinical Oncology2019-05-2075 citations
Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
2019-05-0868 citations
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
BMJ Open2019-03-01302 citations
Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial
BMJ Open2018-05-0124 citations